Winnie H. Wan
Direktor/Vorstandsmitglied bei Inhalon Biopharma, Inc.
Aktive Positionen von Winnie H. Wan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Inhalon Biopharma, Inc.
 Inhalon Biopharma, Inc. BiotechnologyHealth Technology Inhalon Biopharma, Inc. operates as a biotechnology company. It develops an inhaled immunotherapy platform for treating acute respiratory infections. The company is headquartered in Carrboro, NC. | Direktor/Vorstandsmitglied | - | - |
Life Science Angels
 Life Science Angels Investment ManagersFinance Life Science Angels (Life Science Angels) is a venture capital subsidiary of Life Science Angels, Inc. founded in 2004 by Allan W. May, Greg B. Scott and J. Casey McGlynn. The firm is headquartered in Sunnyvale, California. | Direktor/Vorstandsmitglied | 01.02.2018 | - |
Kryptos Biotechnologies, Inc.
 Kryptos Biotechnologies, Inc. Packaged SoftwareTechnology Services Kryptos Biotechnologies, Inc engages in the development of life science tools that capture genuine status of each cell to present unbiased genomic characteristics. The company was founded by Jin Yong Lee and Jun Ho Son in 2017 and is headquartered in Hayward, CA. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
Chameleon Biosciences, Inc.
 Chameleon Biosciences, Inc. BiotechnologyHealth Technology Chameleon Biosciences, Inc. engages in the provision of a pre-clinical stage gene therapy. The company was founded by Genine Winslow and Jeffery Scott Vick and is headquartered in Berkeley, CA. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
Saccharo, Inc.
 Saccharo, Inc. Pharmaceuticals: MajorHealth Technology Saccharo, Inc. is a biotech startup located in Oakland, CA. The company is focused on developing products for a novel polysaccharide target found only on cancer cells, not on normal cells, which is constant across all stages and types of cancer. This target is involved in a unique immune shielding pathway and serves as a platform for multiple drug modalities. Sheryl Martin-Moe has been the CEO of the company since 2017. | Direktor/Vorstandsmitglied | 01.11.2020 | - |
| Berater | 01.11.2020 | - |
Karriereverlauf von Winnie H. Wan
Ehemalige bekannte Positionen von Winnie H. Wan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GeneTrol Biotherapeutics, Inc. | Gründer | 01.01.2002 | 01.01.2002 |
| Präsident | - | 01.01.2002 | |
Guava Technologies, Inc.
 Guava Technologies, Inc. BiotechnologyHealth Technology Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA. | Direktor/Vorstandsmitglied | 01.01.1997 | 01.01.2001 |
| BECTON, DICKINSON AND COMPANY | Präsident | 01.01.1991 | 01.01.1996 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Private Equity Investor | 01.01.1988 | 01.01.1990 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - | |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Winnie H. Wan
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Yale University | Doctorate Degree |
| Skidmore College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 20 |
Operativ
| Director/Board Member | 10 |
| Founder | 3 |
| Corporate Officer/Principal | 3 |
Sektoral
| Health Technology | 13 |
| Consumer Services | 4 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 14 |
|---|---|
ForteBio, Inc.
 ForteBio, Inc. Medical SpecialtiesHealth Technology Pall ForteBio Corp. develops analytical systems that enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics, and concentration. The company was founded in October 2001 and is headquartered in Menlo Park, CA. | Health Technology |
| GeneTrol Biotherapeutics, Inc. | |
Guava Technologies, Inc.
Guava Technologies, Inc. BiotechnologyHealth Technology Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA. | Health Technology |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Bell Biosystems, Inc.
 Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |
OncoHealth Corp.
 OncoHealth Corp. BiotechnologyHealth Technology OncoHealth Corp. operates as a protein biomarker diagnostics company. It commercializes unique proprietary tests for cervical cancer and other cancers associated with human papillomavirus (HPV). The company was founded by Winnie H. Wan and Shuling Cheng in December on July 26, 2010 and is headquartered in Mountain View, CA. | Health Technology |
Nanotech Biomachines, Inc.
 Nanotech Biomachines, Inc. BiotechnologyHealth Technology Nanotech Biomachines, Inc. produces industrial-grade grapheme. It offers are used for computer transistors, radio-frequency transistors for cell phones, batteries, solar cells, printable electronics and touch displays. The company was by founded by Will Martinez and is headquartered in Berkeley, CA. | Health Technology |
Inhalon Biopharma, Inc.
Inhalon Biopharma, Inc. BiotechnologyHealth Technology Inhalon Biopharma, Inc. operates as a biotechnology company. It develops an inhaled immunotherapy platform for treating acute respiratory infections. The company is headquartered in Carrboro, NC. | Health Technology |
Somatix Therapy Corp.
 Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Health Technology |
Life Science Angels
Life Science Angels Investment ManagersFinance Life Science Angels (Life Science Angels) is a venture capital subsidiary of Life Science Angels, Inc. founded in 2004 by Allan W. May, Greg B. Scott and J. Casey McGlynn. The firm is headquartered in Sunnyvale, California. | Finance |
Kryptos Biotechnologies, Inc.
Kryptos Biotechnologies, Inc. Packaged SoftwareTechnology Services Kryptos Biotechnologies, Inc engages in the development of life science tools that capture genuine status of each cell to present unbiased genomic characteristics. The company was founded by Jin Yong Lee and Jun Ho Son in 2017 and is headquartered in Hayward, CA. | Technology Services |
Chameleon Biosciences, Inc.
Chameleon Biosciences, Inc. BiotechnologyHealth Technology Chameleon Biosciences, Inc. engages in the provision of a pre-clinical stage gene therapy. The company was founded by Genine Winslow and Jeffery Scott Vick and is headquartered in Berkeley, CA. | Health Technology |
Saccharo, Inc.
Saccharo, Inc. Pharmaceuticals: MajorHealth Technology Saccharo, Inc. is a biotech startup located in Oakland, CA. The company is focused on developing products for a novel polysaccharide target found only on cancer cells, not on normal cells, which is constant across all stages and types of cancer. This target is involved in a unique immune shielding pathway and serves as a platform for multiple drug modalities. Sheryl Martin-Moe has been the CEO of the company since 2017. | Health Technology |
- Börse
- Insiders
- Winnie H. Wan
- Erfahrung
